Genetically engineered viruses: a medicine of the future
A medical team at Johns Hopkins University genetically engineered a common cold virus to deposit a gene when injected into the human eye. This gene codes for a protein that binds to VEGF, another protein whose activity in old age contributes to vision loss (a disease called AMD or wet AMD). This small clinical study’s preliminary results show that just one small dose is potent enough to improve a patient’s vision loss. Continue reading Genetically engineered viruses: a medicine of the future